Northwest Bancshares’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-30,635
Closed -$3.04M 149
2019
Q3
$3.04M Buy
30,635
+642
+2% +$61K 1.26% 29
2019
Q2
$2.77M Sell
29,993
-4,435
-13% -$421K 1.17% 33
2019
Q1
$3.25M Buy
34,428
+2,216
+7% +$194K 1.4% 18
2018
Q4
$2.06M Buy
32,212
+18,692
+138% +$1.38M 1% 42
2018
Q3
$1.21M Buy
13,520
+6,629
+96% +$586K 0.54% 64
2018
Q2
$547K Buy
6,891
+2,122
+44% +$176K 0.23% 90
2018
Q1
$425K Sell
4,769
-276
-5% -$26.5K 0.17% 101
2017
Q4
$526K Buy
+5,045
New +$569K 0.21% 92

Other funds holding CELG

Northwest Bancshares's CELG Position: Q4 2019 in Review

Northwest Bancshares sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 30,635 shares — an estimated $3.04M sold.

Northwest Bancshares first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $3.25M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Northwest Bancshares reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Northwest Bancshares sold 30,635 Celgene Corp shares in Q4 2019, an estimated $3.04M.
  • Northwest Bancshares first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • Northwest Bancshares's Celgene Corp position peaked at $3.25M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Northwest Bancshares's 13F filing for Q4 2019, filed 10 Feb 2020.